Toxicology, Cancer, Pharmacology, and Pharmacy Consultant and Expert Witness
Dr. Harry A. Milman has served as a toxicology, cancer, pharmacology, and pharmacy consultant and expert witness since 1998. After his 30 year career in the US federal government, Dr. Milman turned to consulting and litigation support as an expert witness for both defense and plaintiff attorneys. In addition, Dr. Milman evaluates medical records (toxicology and pre-clinical pharmacology) and testifies at depositions and jury trials on issues related to the following topics.
Background and Experience
US National Cancer Institute, NIH
Dr. Milman was a research scientist at the US National Cancer Institute (NCI) of the National Institutes of Health (NIH) for 10 years. He conducted research in cancer treatment, childhood leukemia, and pancreatic cancer while in the Laboratory of Toxicology. After that, Dr. Milman managed, monitored, and designed long-term animal cancer and toxicology studies as part of the Carcinogenesis Testing Program.
US Environmental Protection Agency
Dr. Milman was a Senior Toxicologist and Senior Science Advisor for nearly 20 years at the US Environmental Protection Agency (EPA). In the Office of Pollution Prevention and Toxic Substances (OPPT), Dr. Milman evaluated over 200 cancer and toxicology studies and performed many health assessments under Sections 4, 5, and 6 of the Toxic Substances Control Act (TSCA).
As Chairman of the Health Research Subcommittee for OPPT, Dr. Milman directed agency research priorities and coordinated scientific activities between the EPA, the National Toxicology Program (NTP), the Agency for Toxic Substances and Disease Registry (ATSDR), and various national and international health organizations.
While in the Office of International Activities, Dr. Milman coordinated agency participation in the World Health Organization (WHO), the Organization for Economic Cooperation and Development (OECD), and the International Program on Chemical Safety (IPCS). Dr. Milman also provided guidance to the regulated industry involved in international transport of hazardous wastes.
Lastly, Dr. Milman managed the preparation of preliminary guidelines for “Risk-Risk Tradeoff” and implemented a research program on the use of biochemical and immunological markers as early indicators of cancer.
Dr. Milman was a licensed pharmacist in New York and Maryland for about 35 years. He also served as the first pharmacist at the White Earth Indian Health Center in Minnesota (1968-1970).
Harry A. Milman received his Doctorate in Pharmacology from the George Washington University, his Master of Science in Pharmaceutics from St. John’s University, and his Bachelor of Science in Pharmacy from Columbia University.
Professional Affiliations and Activities
Dr. Milman is a member of the Society of Toxicology and served as President of the National Capital Area Chapter of the Society of Toxicology from 2005 to 2006. He is also a member of the American Society for Pharmacology and Experimental Therapeutics (ASPET) and the American Pharmacists Association (APhA).
Dr. Milman has also organized or presented at more than 20 national or international conferences and has edited five books, including the widely used Handbook of Carcinogen Testing.
Throughout his career, Dr. Milman has received three US Public Health Service Citations, the US Public Health Service Commendation Medal, and the US Environmental Protection Agency Bronze Medal for Commendable Service.
For More Information
For more information regarding his services as a toxicology, cancer, pharmacology, and pharmacy consultant and expert witness, please contact him by phone at 301-871-6715 or by email at email@example.com.